Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Rebecca B Roberts is Director at AbbVie. OQRO lists 1 transaction filed with the SEC under this name, the latest on May 12, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
As of the latest filing on , Rebecca B Roberts reported holding 14,846 shares of AbbVie (ABBV), worth about $4.25M at the last close of $286 (Nov 18, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| AbbVie ABBV | 14,846 | 15K direct | $286 | $4.25M | May 8, 2026 |
Is this Rebecca B Roberts’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
AbbVieABBV
May 8, 20261,118disclosed May 12
DetailsOfficial recordRebecca B Roberts bought shares on the open market in 2011, and has not bought since 2011 across 2 companies. Sales in 4 of the 16 years since 2011.
Rebecca B Roberts reported 1 open-market purchase and 16 sales since 2011; purchases in 2011.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | $370K11×11 trades |
| 2023 | — | $353K2×2 trades |
| 2022 | — | $101K2×2 trades |
| 2020 | — | $140K1×1 trade |
| 2011 | $100K1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated May 8, 2026, Rebecca B Roberts reported holding 14,846 shares of AbbVie (ABBV). At the last close of $286 on Nov 18, 2026, that is about $4.25M. This is the stake disclosed in filings, not a net worth.
No public filing gives Rebecca B Roberts's net worth. What SEC Form 4 shows is the stock stake: 14,846 shares of AbbVie (ABBV), about $4.25M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Rebecca B Roberts bought shares on the open market in 2011, and has not bought since 2011 across 2 companies. Sales in 4 of the 16 years since 2011.
In SEC filings since 2011: the latest open-market purchase is from 2011; the latest open-market sale is from 2024.
2 companies: Black Hills Corporation (BKH, 2011–2024), MSA Safety (MSA, 2020–2024).
Rebecca B Roberts reported 1 open-market purchase and 11 sales here, 2011 to 2024.
Rebecca B Roberts reported 0 open-market purchases and 5 sales here, 2020 to 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.